Vaccines

Advancing
Global Vaccine Development
with Proven
Clinical Excellence.

Vaccines remain one of the most impactful medical innovations, playing a vital role in preventing infectious diseases and protecting global health. Their successful development requires robust clinical research, scientific expertise, and seamless operational execution.

At Cliantha Research, we are proud to support vaccine development through our comprehensive clinical research capabilities. With extensive experience in conducting vaccine clinical trials, our multidisciplinary teams are well equipped to manage complex study designs while maintaining the highest standards of quality, safety, and regulatory compliance.

Our site network, experienced investigators, and dedicated project teams enable the efficient execution of vaccine studies across diverse populations. From early-phase trials to large-scale studies, we work closely with global pharmaceutical and biotechnology partners to generate reliable data that supports regulatory submissions and accelerates development timelines.

Through scientific rigor, operational excellence, and a strong commitment to participant safety, we continue to contribute to the development of safe and effective vaccines that can make a meaningful difference in public health worldwide.

08

Studies

90+

Sites

9000+

Patients

VACCINE EXPERIENCE THAT MATTERS

Our areas of expertise

Viral Vaccines

  • Measles and Rubella
  • Mumps
  • Rabies

Bacterial Vaccines

  • Typhoid
2 GCP/GLP Compliant laboratories- Ahmedabad, India and Toronto, Canada
State-of-the-art infrastructure – LCMS/MS, ICP-MS, MSD/ECL platforms and more
950+

Validated assays

50+

New Methods Evaluated Every Year

1.2+ Million

Sample Analysis Capacity

Explore our end-to-end services

End-to-end solutions

Site Network

Patient Recruitment

Regulatory Services

Decentralized Clinical Trials (DCT)

START YOUR VACCINE TRIAL JOURNEY WITH THE RIGHT PARTNER.